SOPHARMA AD: Notification for technical error correction

opublikowano: 2019-12-16 09:58

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_88_correction_espi.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 88 / 2019
Date of issue: 2019-12-16
Short name of the issuer
SOPHARMA AD
Subject
Notification for technical error correction
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, December 16, 2019 - Sopharma AD notifies that due to a technical error in the Notification for treasury shares, published on December 13, 2019, please read the sum of the total value of treasury shares “BGN 142 442,436”, instead of “BGN 412 443,26”.

We apologize for the inconvenience.

Please, on the grounds of Art. 100k, para. 1 of the POSA make the above information public.
Annexes
File Description
Current report_88_correction_espi.pdfCurrent report_88_correction_espi.pdf Notification for technical error correction

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2019-12-16 Ognian Donev Executive Director